Choose antibacterial carefully when treating methicillin-resistant Staphylococcus aureus diabetic foot infections

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.7, 2011-07, pp. : 10-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections

By Eleftheriadou Ioanna

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1785-1797

Adis International

Access to resources Recommend Favorite

Treatment Strategies for Methicillin-Resistant Staphylococcus aureus Infections in Pediatrics

By Newland Jason G. Kearns Gregory L.

Pediatric Drugs, Vol. 10, Iss. 6, 2008-01 ,pp. : 367-378

Adis International

Access to resources Recommend Favorite

Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections

Current Drug Metabolism, Vol. 10, Iss. 8, 2009-10 ,pp. : 875-884

Bentham Science Publishers

Access to resources Recommend Favorite

Antibacterial Agents Against Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE)

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 4, 2007-10 ,pp. : 243-247

Bentham Science Publishers

Access to resources Recommend Favorite

Antibacterial Effects of Moxifloxacin and Levofloxacin Simulating Epithelial Lining Fluid Concentrations against Community-Acquired Methicillin-Resistant Staphylococcus aureus

By Su Young Lee Hong Wei Fan Sutherland Christina DeRyke Andrew C. Nicolau David P.

Drugs in R&D, Vol. 8, Iss. 2, 2007-01 ,pp. : 69-77

Adis International

Access to resources Recommend Favorite